Reduced T-cell Numbers and Elevated Levels of Immunomodulatory Cytokines in Metastatic Prostate Cancer Patients De Novo Resistant to Abiraterone and/or Enzalutamide Therapy

Pal, S. K., Moreira, D., Won, H., White, S. W., Duttagupta, P., Lucia, M., Jones, J., Hsu, J., Kortylewski, M.  Reduced T-cell Numbers and Elevated Levels of Immunomodulatory Cytokines in Metastatic Prostate Cancer Patients De Novo Resistant to Abiraterone and/or Enzalutamide Therapy.  International Journal Of Molecular Sciences. 2019; 20(8), 1831.  doi:10.3390/ijms20081831